Resolution on the results of the Council of Experts on the topic: “Infantile hemangioma is an interdisciplinary problem that has a unified solution: from detection/diagnosis and treatment to reimbursement”
T. S. Belysheva,
S. R. Varfolomeeva,
I. N. Zakharova,
A. V. Zuev,
N. P. Katukova,
Yu. A. Polyaev,
V. K. Fedyaeva,
K. I. Kyrgyzov,
G. B. Sagoyan https://doi.org/10.21682/2311-1267-2022-9-4-119-121
Abstract
On October 19, 2022, the Council of Experts considered and discussed a number of issues related to the treatment of patients with infantile hemangioma in the Russian Federation.
About the Authors
T. S. Belysheva
Federal State Budgetary Institution National Medical Research Center of Oncology named after N. N. Blokhin” of the Ministry of Health of Russia
Russian Federation
Russian Federation
Tatyana Sergeevna Belysheva, Doctor of Medical Sciences, Leading Researcher
Research Institute of Pediatric Oncology and Hematology
scientific advisory department
Moscow
S. R. Varfolomeeva
Federal State Budgetary Institution National Medical Research Center of Oncology named after N. N. Blokhin” of the Ministry of Health of Russia
Russian Federation
Russian Federation
Svetlana Rafaelevna Varfolomeeva, Doctor of Medical Sciences, Professor, Director
Research Institute of Pediatric Oncology and Hematology
Moscow
I. N. Zakharova
FGBOU DPO RMANPO of the Ministry of Health of Russia
Russian Federation
Russian Federation
Irina Nikolaevna Zakharova, Doctor of Medical Sciences, Professor, Honored Doctor of the Russian Federation, Head of the Department
Department of Pediatrics. acad. G. N. Speransky
Moscow
A. V. Zuev
FGBU TsEKKMP of the Ministry of Health of Russia
Russian Federation
Russian Federation
Alexander Vladimirovich Zuev, head of department
department of methodological support of methods of payment for medical care
Moscow
N. P. Katukova
FGAOU VO RNIMU them. N. I. Pirogov of the Ministry of Health of Russia; GBUZ "DGKB im. Z. A. Bashlyaeva DZM "
Russian Federation
Russian Federation
Natalya Pavlovna Kotlukova, Doctor of Medical Sciences, Professor, Professor of the Department, Head
Department of Hospital Pediatrics. acad. V. A. Tabolina
Competence center for the treatment of infants
hemangioma
Moscow
Yu. A. Polyaev
FGAOU VO RNIMU them. N. I. Pirogov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Yuri Aleksandrovich Polyaev, Doctor of Medical Sciences, Professor, Head of Department
Russian Children's Clinical Hospital
Department of X-ray Surgical Methods of Diagnosis and Treatment
Moscow
V. K. Fedyaeva
FSBI "Research Financial Institute" of the Ministry of Finance of the Russian Federation
Russian Federation
Russian Federation
Vlada Konstantinovna Fedyaeva, research laboratory assistant
Center for Finance in Healthcare
Moscow
K. I. Kyrgyzov
Federal State Budgetary Institution National Medical Research Center of Oncology named after N.N. N. N. Blokhin” of the Ministry of Health of Russia
Russian Federation
Russian Federation
Kirill Igorevich Kirgizov, event moderator, deputy director for scientific and educational work, executive director of NODGO, Ph.D.
Research Institute of Pediatric Oncology and Hematology
Moscow
G. B. Sagoyan
Federal State Budgetary Institution National Medical Research Center of Oncology named after N.N. N. N. Blokhin” of the Ministry of Health of Russia
Russian Federation
Russian Federation
Garik Barisovich Sagoyan, event secretary, researcher, pediatric oncologist, executive secretary of the NODGO
Research Institute of Pediatric Oncology and Hematology
pediatric oncology department of surgical methods of treatment with chemotherapy No. 2 (tumors of thoracoabdominal localization)
Moscow
References
1. Munden A., Butschek R., Tom W. L., Marshall J. S., Poeltler D. M., Krohne S. E., Alió A. B., Ritter M., Friedlander D. F., Catanzarite V., Mendoza A., Smith L., Friedlander M., Friedlander S. F. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014; 170 (4): 907–13. doi: 10.1111/bjd.12804.
2. Krowchuk D. P., Frieden I. J., Mancini A. J., Darrow D. H., Blei F., Greene A. K., Annam A., Baker C. N., Frommelt P. C., Hodak A., Pate B. M., Pelletier J. L., Sandrock D., Weinberg S. T., Whelan M. A.; SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE HEMANGIOMAS. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics. 2019; 143 (1): e20183475. doi: 10.1542/peds.2018-3475.
3. Dyakov I. N. Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy / I. N. Dyakov, S. R. Varfolomeeva // PHARMAKOEKONOMIKA. Modern pharmacoeconomics and pharmacoepidemiology. – 2020; 13 (4): 356–65. doi: 10.17749/2070-4909/farmakoekonomika.2020.073.
Review
For citations:
Belysheva T.S., Varfolomeeva S.R., Zakharova I.N., Zuev A.V., Katukova N.P., Polyaev Yu.A., Fedyaeva V.K., Kyrgyzov K.I., Sagoyan G.B. Resolution on the results of the Council of Experts on the topic: “Infantile hemangioma is an interdisciplinary problem that has a unified solution: from detection/diagnosis and treatment to reimbursement”. Russian Journal of Pediatric Hematology and Oncology. 2022;9(4):119-121. (In Russ.) https://doi.org/10.21682/2311-1267-2022-9-4-119-121
Views:
372
Email this article 